Navigation Links
Simbionix and AABIP Sign Collaboration Agreement
Date:11/2/2010

Simbionix and AABIP Sign Collaboration Agreement -- CLEVELAND, November 2, 2010 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Health Care & Hospitals, Medical Equipment, Medical Pharmaceuticals, Education, Contracts, Joint Ventures, New Products & Services Click to view news release full screen  

Simbionix and AABIP Sign Collaboration Agreement

 

CLEVELAND, November 2, 2010 /PRNewswire/ -- Simbionix USA Corporation, the world's leading provider of medical education and simulation technology, is pleased to announce they have signed a collaboration agreement with the American Association for Bronchology and Interventional Pulmonology (AABIP) on the development of a Bronchoscopic Essential Skills module.

Simbionix new Bronchoscopy essential skills module is being developed in conjunction with, and endorsed by the AABIP. The new module offers designated skill tasks covering the spectrum of Bronchoscopic skills required. This module is intended to provide the trainee with solid habits for safe and efficient performance, and to enhance hand-eye coordination, 3D perception and anatomical knowledge.

Gerard Silvestri, AABIP President, said that "The daily practice of clinicians is highly affected by the progression of medical technologies, as they are required to adapt to fast changes and developments. It is therefore essential to develop new training programs that utilize the advanced technologies, such as virtual reality simulators, to assure that the educational curriculum is entirely covered. We chose to work with simbionix since we believe that only close collaboration between the medical community and companies that provide cutting edge technologies are essential to successfuly design these programs for the benefit of the physicians, the patients and the entire medical field."

"We are very excited to have reached yet another collaboration agreement with a leading medical society" commented Mr. Ran Bronstein, Simbionix President. "All of our products are designed with the cooperation of the medical community, who play an active role in simulation design, content definition, and product testing and validation. Simbionix continuously provides the procedural and technological know-how and actively joins forces with the leading medical associations and the medical industry to optimize training solutions and to advance clinical performance."

About Simbionix USA Corporation

Simbionix is the world's leading provider of simulation and training products for medical professionals and the healthcare industry. Founded in 1997, the company is committed to delivering high quality products, advancing clinical performance and optimizing procedural outcomes.

For more information on Simbionix, visit http://www.simbionix.com

About the American Association for Bronchology and Interventional Pulmonology

AABIP is dedicated to promoting excellence in clinical care, education, and research in the rapidly expanding fields of Bronchoscopy, Interventional Pulmonology, and Interventional Bronchoscopy.

For more information on the AABIP, visit http://www.aabronchology.org Contact: Rebecca Zitter Manager of Marketing Communications and Distributor Relations rebecca@simbionix.com +1-216-2292040
'/>"/>

SOURCE Simbionix Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Simbionix and Johnson & Johnson LLC Announce Distribution Agreement at Russia and the CIS Countries
2. Simbionix Introduces the Next Generation in Bronchoscopy Training
3. Simbionix Welcomes Two New Members to Expand Compays Medical Education Product Offerings
4. Simbionix and USF Receive Grant to Support Development of Laparoscopic Hysterectomy Simulation
5. LigoCyte Pharmaceuticals Announces Collaboration With Biogen Idec to Develop Anti-CD103 Therapies
6. Phase 2 Clinical Studies Initiated for a Novel Therapeutic Candidate Identified Through Pharmacopeia Collaboration
7. Quark Pharmaceuticals Signs Collaboration Agreement With University of Michigan for Development of Proprietary SiRNA Compounds for Noise-Induced Hearing Loss
8. Synvista Collaboration Demonstrates in Preclinical Studies the Mechanism for Defective Cholesterol Transport in Patients with Diabetes
9. GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution
10. Ambrx Enters FGF-21 Type 2 Diabetes Drug Discovery Collaboration with Merck and Co. Inc.
11. Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... CTI BioPharma Corp. (CTI BioPharma) (NASDAQ ... the clinical studies being conducted under the Company,s ... the issuance of the Company,s February 8, 2016, ... by the U.S. Food and Drug Administration (FDA) ... oral communication from the FDA followed by a ...
(Date:2/10/2016)... Demonstrates changes in brain ... selectivity   1 receptor agonist, ... clinical development as a new treatment for cognitive ... --> 1 receptor agonist, designed ... development as a new treatment for cognitive impairment ...
(Date:2/9/2016)... (NYSE: LDR ), a recognized leader in personal ... services and high quality medical consumable accessories, today reported ... December 31, 2015. --> ... , Revenue of $36.5 million compared to $37.5 million ... Measurement services revenues increased 2.8% year-over-year , Medical ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... 09, 2016 , ... Traumatic Brian Injury is often in ... one of many possible sources: sports, car accidents, falls, work accidents, combat and ... Rehab Solutions for the Complexities of Concussions is designed for physical and ...
(Date:2/9/2016)... ... 09, 2016 , ... Center for Autism and Related Disorders ... spectrum disorder (ASD). Beginning Jan. 1, 2016, Medicaid is covering autism treatment in ... key to providing effective treatment for individuals with ASD. Now, over 1,800 low-income ...
(Date:2/9/2016)... ... February 09, 2016 , ... URise Products announces today ... device, the StandUp Walker. Made entirely in the USA, the StandUp Walker is ... , StandUp Walker’s novel patent-pending design offers 2-in-1 benefits of a stand-assist ...
(Date:2/9/2016)... (PRWEB) , ... February 09, ... ... print and e-book publishing software, in partnership with Snowfall4pod Digital, creators of ... a comprehensive book publishing, content management, global distribution and print-on-demand network. , ...
(Date:2/9/2016)... ... February 09, 2016 , ... On January 12, 2016 Paul McElwee, a ... they noticed their furnace not producing any heat. Shortly after entering the home, Paul ... exchanger was leaking dangerous levels of carbon monoxide into the home, at 2,000 parts ...
Breaking Medicine News(10 mins):